Plasmacytoma

This is a type of cancer that starts in plasma cells. Plasma cells are a type of white blood cell that normally helps fight infection. A plasmacytoma is a solid mass of these cancer cells, usually found in the bone marrow. It's considered a localized form of multiple myeloma, which is a more widespread cancer.

Condition

What people with Plasmacytoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Radiation Therapy for Plasmacytoma?

NameHow it went

About Plasmacytoma

What It Is

A plasmacytoma is a cancer made of abnormal plasma cells that forms a single tumor in one place in the body. Plasma cells are white blood cells that normally make antibodies to fight infection. When one line of them grows out of control in a single spot, it can form a mass that damages the tissue around it. There are two main types. A solitary plasmacytoma of bone grows inside a bone, most often a vertebra in the spine, the pelvis, a rib or the thigh bone, and it can cause pain or weaken the bone enough to break. An extramedullary plasmacytoma grows in soft tissue outside the bone, most often in the sinuses, nose, throat or tonsils, where it can press on nearby structures and cause a lump, pain, a blocked feeling or trouble swallowing, depending on where it sits. Plasmacytoma is closely related to multiple myeloma, a cancer of the same cells that is spread through the bone marrow. The difference is that a plasmacytoma is limited to one site. That matters because a single tumor can often be treated with the aim of cure, but some people go on to develop myeloma later.

Causes & Risk Factors

In most people there is no identifiable cause. Plasmacytoma is rare and is most common in middle-aged and older adults. As with multiple myeloma, it occurs more often in men and in Black people, and exposure to radiation or certain chemicals has been linked to plasma cell cancers. Some people with a plasmacytoma have a small amount of abnormal protein (called an M protein) in their blood or urine, a sign that the same abnormal plasma cells are producing antibody fragments. A related, usually harmless condition called MGUS (monoclonal gammopathy of undetermined significance) also involves an M protein and raises the long-term risk of plasma cell cancers. These are associations, not a predictable path, and most people with these risk factors never develop a plasmacytoma.

How It's Diagnosed

A plasmacytoma is often found after imaging for bone pain or a fracture, or after a soft tissue lump is examined. The diagnosis is confirmed with a biopsy, in which a sample of the tumor is examined under a microscope to show that it is made of abnormal plasma cells. The rest of the evaluation answers a second question: is this truly a single tumor, or is it the first sign of multiple myeloma? A bone marrow aspiration and biopsy, usually taken from the hip bone, checks how many abnormal plasma cells are in the marrow elsewhere. If abnormal plasma cells make up 10% or more of the marrow, the diagnosis is myeloma rather than plasmacytoma, and even a smaller number of abnormal cells raises the chance of later progression. Blood and urine tests look for M protein and measure free light chains (small antibody pieces made by the abnormal cells), along with blood counts, calcium and kidney function. Sensitive whole-body imaging is essential because ordinary X-rays can miss small areas of disease. MRI of the spine and pelvis or a PET/CT scan (positron emission tomography combined with CT, which highlights active tumor) is used to look for other lesions. Finding additional spots changes both the diagnosis and the treatment plan.

Treatment Options

Plasma cell tumors are very sensitive to radiation, so radiation therapy aimed at the tumor is the standard treatment for both types. It is usually given in short daily sessions over about four weeks, and it controls the treated tumor in most people. For extramedullary plasmacytoma in particular, radiation is often curative. Side effects depend on the part of the body treated: radiation to the head and neck can cause mouth and throat soreness, taste changes or trouble swallowing, while radiation to the pelvis may cause diarrhea or bladder irritation. Skin changes over the treated area and fatigue are common, and most of these effects ease within a few months. Surgery has a narrower role. For a bone plasmacytoma, it is used to stabilize a broken or weakened bone, or to relieve pressure on the spinal cord or nerves. For a soft tissue tumor in an accessible place such as a tonsil, surgeons may remove it. In either case radiation usually follows, because removing the tumor without radiation leads to a high rate of regrowth. Chemotherapy or other myeloma drugs are not routinely added after successful radiation, because studies have not shown a clear benefit. They come into play if the tumor does not respond fully, if new lesions appear or if the condition progresses to multiple myeloma, which has its own range of effective treatments.

What to Expect

Most people complete radiation and return to their usual activities, although recovery depends on where the tumor was. A bone plasmacytoma in the spine or a weight-bearing bone may require time to heal and some changes to activity, and a tumor in the throat or sinuses can leave temporary trouble with eating or taste after treatment. The scan appearance of a treated bone may take a year or more to settle, and any M protein in the blood may fall slowly over months. The main long-term question is whether multiple myeloma develops. This is more likely with a bone plasmacytoma, where about half of people develop myeloma within ten years, than with an extramedullary plasmacytoma, where it is closer to a third. Abnormal plasma cells in the marrow at diagnosis, an M protein that persists after radiation or an abnormal free light chain result point to higher risk. Many people, especially those with soft tissue tumors, remain free of disease for many years. Follow-up therefore continues long after treatment ends. It typically involves regular blood and urine protein tests and periodic imaging, more often in the first few years. If myeloma develops, catching it through monitoring allows treatment to start before it causes serious bone, kidney or blood problems.

When to Seek Help

See a doctor about bone pain that persists or worsens without a clear reason, or a lump, a blocked feeling in the nose or throat, or difficulty swallowing that does not settle. After treatment, keep scheduled follow-up tests even when you feel well. If you have had a plasmacytoma, contact your care team promptly about new or worsening back pain, especially pain that is severe, wakes you at night or gets worse with coughing or straining, and about new bone pain elsewhere, unusual fatigue or frequent infections, which can be early signs of myeloma. New weakness or numbness in the legs, difficulty walking, or loss of bladder or bowel control can mean the spinal cord is being compressed. This is an emergency: go to an emergency department right away, because prompt treatment can protect movement and function.

Questions to Ask Your Doctor

  1. 1.Is my plasmacytoma in bone or in soft tissue, and how does that affect my outlook?
  2. 2.Did the bone marrow test and scans show any other signs of disease, and what is my risk of developing multiple myeloma?
  3. 3.What side effects should I expect from radiation to this area, and how will we know it worked?
  4. 4.Which tests will I need during follow-up, how often, and for how many years?
  5. 5.If the bone is weakened, what activities should I avoid while it heals?

Last reviewed • Oct 2026

Educational content, not medical advice.